anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Spyre Therapeutics · pitchdeck

Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides

38 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides

Spyre Therapeutics · 2023-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 7 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 9 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Situation & Context 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits
— 0/2 slides
50% 1/2 slides 50% 1/2 slides 100% 2/2 slides
— 0/2 slides
Evidence & Proof 3 slides 100% 3/3 slides 100% 3/3 slides · 14 hits
— 0/3 slides
33.3% 1/3 slides
— 0/3 slides
100% 3/3 slides
— 0/3 slides

Slide inventory

38
every slide · same image gating as the playbook
01
Slide 1
The slide features a split design with a white left side containing logos and a dark purple abstract background on the right.front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a Gantt-style chart to show the development stage of multiple drug programs.plan_implementation
Open slide detailBeat · Situation & Context
04
The slide uses a three-column layout to compare product candidates.present_solution
Open slide detailBeat · Situation & Context
05
The chart is a scatter plot showing maintenance remission rates vs. dosing frequency, positioning current therapies in a cluster and the company's target in a sframe_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
06
The slide uses a three-column layout to present the company's core technological approaches.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
07
The chart uses a horizontal bar representation to indicate progress through discovery and IND-enabling stages.plan_implementation
Open slide detailLoop · Quick Win Big Bet
08
The slide uses a split-screen layout with a photo of a person on the right and branding on the left.front_matter
Open slide detailLoop · Quick Win Big Bet
09
present_solution
Open slide detailBeat · Evidence & Proof
10
Includes structural biology visualization, dose-response curves, and a binding affinity table.present_solution
Open slide detailBeat · Evidence & Proof
11
Pharmacokinetic study results showing extended half-life for the drug candidate.show_traction
Open slide detailBeat · Evidence & Proof
12
The slide outlines a standard clinical trial progression for SAD and MAD cohorts, including randomization ratios and participant types.present_framework
Open slide detail
13
summarize
Open slide detail
14
Includes PK modeling data comparing human and NHP half-lives and steady-state concentration simulations.analyze_data
Open slide detail
15
Uses icon-based visualization to represent injection frequency.compare_peers
Open slide detail
16
The slide uses a bar chart to show dose-response correlation and a line chart to show pharmacokinetic modeling.analyze_data
Open slide detail
17
The slide uses a timeline-like visual to compare dosing schedules at weeks 0, 2, and 6.compare_peers
Open slide detail
18
The slide uses two distinct data visualizations: a table for clinical safety metrics and a bar chart for ADA rates.compare_peers
Open slide detail
19
summarize
Open slide detail
20
Features a stylized antibody icon overlay on a photo of a person.front_matter
Open slide detail
21
present_solution
Open slide detail
22
The slide uses a funnel diagram to illustrate the selection process from initial discovery sets to final candidate properties.present_solution
Open slide detail
23
The slide uses two distinct chart types: a scatter plot for binding affinity and a dose-response curve for functional inhibition.present_solution
Open slide detail
24
compare_peers
Open slide detail
25
The slide uses a timeline to frame recent industry activity as validation for the company's asset.cite_precedent
Open slide detail
26
summarize
Open slide detail
27
The graphic overlays on the photo are stylized representations of antibodies, suggesting a biotech/pharma context.transition
Open slide detail
28
present_solution
Open slide detail
29
The slide uses a biological process diagram to map drug targets to specific cellular mechanisms (T-cell trafficking, Colonic Fibrosis, Inflammatory cascade, Th1present_solution
Open slide detail
30
The chart uses a stacked bar to visualize the additive nature of the combination therapy compared to the individual components.compare_peers
Open slide detail
31
The table highlights that Spyre's products possess specific safety and efficacy features (no black box warning, dual mechanism, extended half-life) that the comcompare_peers
Open slide detail
32
summarize
Open slide detail
33
transition
Open slide detail
34
The slide includes a section for Management team and Board of Directors with headshots and titles, followed by a logo grid of affiliated organizations.other
Open slide detail
35
The slide combines financial runway with a clinical development timeline.show_traction
Open slide detail
36
state_next_steps
Open slide detail
37
This slide outlines the M&A transaction details including a $210M private placement.other
Open slide detail
38
Includes a footnote regarding a 1-for-25 reverse stock split effective September 8, 2023.analyze_data
Open slide detail